Vivace Therapeutics
Neelesh Sharma MD, PhD currently serves as Senior Vice President of Clinical Development at Prelude Therapeutics since June 2022. Prior to this role, Neelesh held various positions at Bayer Pharmaceuticals, including Vice President and Global Head of Precision Oncology and Senior Clinical Development Leader in Immuno-Oncology. Neelesh also worked as a Clinical Program Leader in Translational Clinical Oncology at Novartis Institutes for BioMedical Research and served as an Assistant Professor in Medical Oncology and Thoracic Oncology at University Hospitals of Cleveland and Case Western Reserve University. Additionally, Neelesh contributed as a member of the NCCN panel for NSCLC, Mesothelioma, and Thymic cancer, and participated in the ECOG Thoracic Committee. Educational credentials include a Fellowship in Medical Oncology from Roswell Park Cancer Institute and a PhD in Pharmacology and Toxicology from The University of Georgia.
This person is not in any teams
This person is not in any offices
Vivace Therapeutics
Vivace Therapeutics is a venture-backed, oncology-focused portfolio-based drug discovery and development company, based in San Mateo, California. Its programs include both small molecule programs targeting the YAP pathway, and bi-specific programs.